Penny Stock Applied Therapeutics' FDA Troubles Trigger Investor Lawsuit, Shareholders Claim Deception Over Govorestat Clinical Data – Yahoo Finance

Investors of penny stock company Applied Therapeutics are taking legal action following FDA troubles and allegations of deception. Shareholders are claiming that they were misled about the clinical data of the company’s drug, Govorestat. The lawsuit comes after the FDA raised concerns about the drug’s effectiveness and safety. The investors are seeking accountability for what they believe to be deceptive practices by the company.